Qingsong Pang
Academic Appointments:
Professor, Radiotherapy department Tiajin Medical University Cancer Hospital
Visiting Scientist in Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX
Education:
2004 - 2007 Ph.D in Radiation Oncology of Tiajin medical University
2002 – 2003 Receiving advanced training for radiation Oncologists in Peking
2000 - 2003 M.M.S in Oncology of Tiajin medical University
Working experience:
2011-now Proseffor , Radiotherapy department Tiajin Medical University Cancer Hospital
2010- 2011 Visiting Scientist in Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX
2007-2009 Associated proseffor , Tiajin Medical University Cancer Hospital
2003-2007 Consultant in Thorax group in Radiotherapy department , Tiajin Medical University Cancer Hospital
PUBLICATIONS:
Zhang W, Pang Qingsong, Zhang X, Yan C, Wang Q, Yang J, Yu S, Liu X, Pan Y, Yuan Z, Wang P, Xiao Z. Programmed death-ligand 1 is prognostic factor in esophageal squamous cell carcinoma and is associated with epidermal growth factor receptor. Cancer Sci. 2017 Apr;108(4):590-597
Zhang W, Pang Qingsong, Yan C, Wang Q. Induction of PD-L1 expression by epidermal growth factor receptor-mediated signaling in esophageal squamous cell carcinoma. Onco Targets Ther. 2017 Feb 13;10:763-771.
Pang Qingsong, Wei Q, Xu T, Yuan X, Lopez Guerra JL, Levy LB, Liu Z, Gomez DR, Zhuang Y, Wang LE, Mohan R, Komaki R, Liao Z. Functional promoter variant rs2868371 of HSPB1 is associated with risk of radiation pneumonitis after chemoradiation for non-small cell lung cancer.Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1332-9
Disclosures:
- Employment: none
- Compensation: none
- Ownership: none
- Leadership: none